196 related articles for article (PubMed ID: 24011515)
1. Cyclodextrin derivatives as anti-infectives.
Karginov VA
Curr Opin Pharmacol; 2013 Oct; 13(5):717-25. PubMed ID: 24011515
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Clostridium perfringens epsilon toxin by β-cyclodextrin derivatives.
Robinson TM; Jicsinszky L; Karginov AV; Karginov VA
Int J Pharm; 2017 Oct; 531(2):714-717. PubMed ID: 28750897
[TBL] [Abstract][Full Text] [Related]
3. Interactions of high-affinity cationic blockers with the translocation pores of B. anthracis, C. botulinum, and C. perfringens binary toxins.
Bezrukov SM; Liu X; Karginov VA; Wein AN; Leppla SH; Popoff MR; Barth H; Nestorovich EM
Biophys J; 2012 Sep; 103(6):1208-17. PubMed ID: 22995493
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of S. aureus alpha-hemolysin and B. anthracis lethal toxin by beta-cyclodextrin derivatives.
Karginov VA; Nestorovich EM; Schmidtmann F; Robinson TM; Yohannes A; Fahmi NE; Bezrukov SM; Hecht SM
Bioorg Med Chem; 2007 Aug; 15(16):5424-31. PubMed ID: 17572091
[TBL] [Abstract][Full Text] [Related]
5. Symmetry requirements for effective blocking of pore-forming toxins: comparative study with alpha-, beta-, and gamma-cyclodextrin derivatives.
Yannakopoulou K; Jicsinszky L; Aggelidou C; Mourtzis N; Robinson TM; Yohannes A; Nestorovich EM; Bezrukov SM; Karginov VA
Antimicrob Agents Chemother; 2011 Jul; 55(7):3594-7. PubMed ID: 21555769
[TBL] [Abstract][Full Text] [Related]
6. In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin.
Moayeri M; Robinson TM; Leppla SH; Karginov VA
Antimicrob Agents Chemother; 2008 Jun; 52(6):2239-41. PubMed ID: 18378717
[TBL] [Abstract][Full Text] [Related]
7. Search for cyclodextrin-based inhibitors of anthrax toxins: synthesis, structural features, and relative activities.
Karginov VA; Nestorovich EM; Yohannes A; Robinson TM; Fahmi NE; Schmidtmann F; Hecht SM; Bezrukov SM
Antimicrob Agents Chemother; 2006 Nov; 50(11):3740-53. PubMed ID: 16982795
[TBL] [Abstract][Full Text] [Related]
8. Tailored ß-cyclodextrin blocks the translocation pores of binary exotoxins from C. botulinum and C. perfringens and protects cells from intoxication.
Nestorovich EM; Karginov VA; Popoff MR; Bezrukov SM; Barth H
PLoS One; 2011; 6(8):e23927. PubMed ID: 21887348
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis, clinical characteristics, diagnostics and treatment of bacterial foodborne diseases].
Müller KE; Rozgonyi F
Orv Hetil; 2020 Nov; 161(48):2019-2028. PubMed ID: 33249408
[TBL] [Abstract][Full Text] [Related]
10. Pore-forming activity of clostridial binary toxins.
Knapp O; Benz R; Popoff MR
Biochim Biophys Acta; 2016 Mar; 1858(3):512-25. PubMed ID: 26278641
[TBL] [Abstract][Full Text] [Related]
11. Revisiting an old antibiotic: bacitracin neutralizes binary bacterial toxins and protects cells from intoxication.
Schnell L; Felix I; Müller B; Sadi M; von Bank F; Papatheodorou P; Popoff MR; Aktories K; Waltenberger E; Benz R; Weichbrodt C; Fauler M; Frick M; Barth H
FASEB J; 2019 Apr; 33(4):5755-5771. PubMed ID: 30699302
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus.
Asha NJ; Tompkins D; Wilcox MH
J Clin Microbiol; 2006 Aug; 44(8):2785-91. PubMed ID: 16891493
[TBL] [Abstract][Full Text] [Related]
13. Rapid clearance of bacteria and their toxins: development of therapeutic proteins.
Kunkel M; Vuyisich M; Gnanakaran G; Bruening GE; Dandekar AM; Civerolo E; Marchalonis JJ; Gupta G
Crit Rev Immunol; 2007; 27(3):233-45. PubMed ID: 18197819
[TBL] [Abstract][Full Text] [Related]
14. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
Uppalapati SR; Kingston JJ; Murali HS; Batra HV
Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of in vitro properties of di-tri-octahedral smectite on clostridial toxins and growth.
Weese JS; Cote NM; deGannes RV
Equine Vet J; 2003 Nov; 35(7):638-41. PubMed ID: 14649353
[TBL] [Abstract][Full Text] [Related]
16. New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.
Beierlein JM; Anderson AC
Curr Med Chem; 2011; 18(33):5083-94. PubMed ID: 22050756
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional analysis of the pore-forming toxin NetB from Clostridium perfringens.
Yan XX; Porter CJ; Hardy SP; Steer D; Smith AI; Quinsey NS; Hughes V; Cheung JK; Keyburn AL; Kaldhusdal M; Moore RJ; Bannam TL; Whisstock JC; Rood JI
mBio; 2013 Feb; 4(1):e00019-13. PubMed ID: 23386432
[TBL] [Abstract][Full Text] [Related]
18. Taguchi optimization of duplex PCR for simultaneous identification of Staphylococcus aureus and Clostridium perfringens alpha toxins.
Ramakrishna US; Kingston JJ; Harishchandra Sripathi M; Batra HV
FEMS Microbiol Lett; 2013 Mar; 340(2):93-100. PubMed ID: 23278425
[TBL] [Abstract][Full Text] [Related]
19. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.
Barth H; Aktories K; Popoff MR; Stiles BG
Microbiol Mol Biol Rev; 2004 Sep; 68(3):373-402, table of contents. PubMed ID: 15353562
[TBL] [Abstract][Full Text] [Related]
20. Cyclophilin-facilitated membrane translocation as pharmacological target to prevent intoxication of mammalian cells by binary clostridial actin ADP-ribosylated toxins.
Ernst K; Langer S; Kaiser E; Osseforth C; Michaelis J; Popoff MR; Schwan C; Aktories K; Kahlert V; Malesevic M; Schiene-Fischer C; Barth H
J Mol Biol; 2015 Mar; 427(6 Pt A):1224-38. PubMed ID: 25058685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
